Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments.

The major components of neurofibrillary tangles (NFT) in Alzheimer's disease are bundles of paired helical filaments (PHF) which are primarily composed of highly phosphorylated tau proteins (PHF-tau). To further understand the mechanism of PHF accumulation in NFT, we examined the calpain-induced proteolysis of highly purified and primarily non-aggregated PHF and normal tau proteins with various contents of phosphate isolated from either fetal (F-tau) or adult human brain (N-tau). The extent of proteolysis was determined by decreases in tau immunoreactivity using Western-blot analysis and a panel of site-specific tau antibodies (Alz 50, Tau-2, Tau 14, Tau-1, AT8, E-11, AH-1 and PHF-1). We found that full-size polypeptides of N-tau and F-tau were similarly and rapidly proteolyzed in vitro by calpain (calpain II, 3.3 units/mg protein) during a 10-min incubation at 30 degrees C, and that their half lives (t1/2) were 1.5 min and 1.8 min, respectively. Analysis of immunoblots suggests that full-length polypeptides of tau are first degraded into large fragments similar in size to that generated endogenously, then into smaller fragments. Since both endogenous and in-vitro-generated tau fragments retained N-terminal epitopes, the results suggest that most of the calpain-sensitive sites may be located in the C-terminal half of the tau molecule. In contrast, PHF were extremely resistant to degradation and only a fivefold higher concentration of calpain (16.7 units/mg protein) induced partial proteolysis of PHF. A major calpain-generated fragment was a 45-kDa polypeptide derived from the C-terminal region of PHF-tau, which forms a core of filaments. The results suggest that the inaccessibility of potential calpain-digestion sites in the filament core could contribute to the resistance of PHF to calpain and subsequently lead to the accumulation of PHF in Alzheimer's disease. The results also suggest that hyperphosphorylation of tau may be marginally involved in the resistance of PHF to degradation by calpain. Ultrastructural examination revealed that, in contrast to previous studies with trypsin, calpain did not alter the morphologic appearance of filaments; after incubation with calpain, the majority of PHF remained short and disperse and the number of PHF aggregated into NFT-like clusters was not significantly increased. The results suggest that the role of calpain in promoting the aggregation and clustering of filaments is limited.

[1]  S. Yen,et al.  Differential expression of exons 10 and 11 in normal tau and tau associated with paired helical filaments , 1995, Journal of neuroscience research.

[2]  M. Mercken,et al.  Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau , 1995, FEBS letters.

[3]  T. Murphy,et al.  A retrospective analysis of peer review at Physiologia Plantarum , 1994 .

[4]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[5]  D. Dickson,et al.  Tau immunoreactivity and SDS solubility of two populations of paired helical filaments that differ in morphology , 1994, Brain Research.

[6]  S. Yen,et al.  The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments , 1993, Brain Research.

[7]  J. Trojanowski,et al.  The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[9]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. W. Scott,et al.  Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms , 1993, Brain Research.

[11]  W. T. Moore,et al.  Application of synthetic phospho‐ and unphospho‐ peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease , 1993, Journal of neuroscience research.

[12]  S. Yen,et al.  Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments , 1992, Brain Research.

[13]  V. Lee,et al.  Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease , 1992 .

[14]  K. Titani,et al.  Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments , 1992 .

[15]  K. Titani,et al.  Tau 2: A Probe for a Ser Conformation in the Amino Terminus of τ , 1992, Journal of neurochemistry.

[16]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[17]  G. Johnson,et al.  Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. , 1992, The Journal of biological chemistry.

[18]  M. Goedert,et al.  Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau , 1991, Neuroscience Letters.

[19]  S. Yen,et al.  Structural stability of paired helical filaments requires microtubule-binding domains of Tau: A model for self-association , 1991, Neuron.

[20]  R. Jope,et al.  Degradation of Microtubule‐Associated Protein 2 and Brain Spectrin by Calpain: A Comparative Study , 1991, Journal of neurochemistry.

[21]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[22]  A. Klug,et al.  Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. , 1990, The American journal of pathology.

[23]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Blomgren,et al.  Calpain and calpastatin in normal and Alzheimer-degenerated human brain tissue , 1990, Neurobiology of Aging.

[25]  S. Yen,et al.  Alzheimer disease proteins (A68) share epitopes with tau but show distinct biochemical properties , 1990, Journal of neuroscience research.

[26]  S. Yen,et al.  Mapping of the Alz 50 epitope in microtubule‐associated proteins tau , 1990, Journal of neuroscience research.

[27]  G. Lynch,et al.  Links between Long‐Term Potentiation and Neuropathology An Hypothesis Involving Calcium‐Activated Proteases , 1989, Annals of the New York Academy of Sciences.

[28]  R. Nixon Calcium‐Activated Neutral Proteinases as Regulators of Cellular Function Implications for Alzheimer's Disease Pathogenesis a , 1989, Annals of the New York Academy of Sciences.

[29]  R. Jope,et al.  Proteolysis of tau by calpain. , 1989, Biochemical and biophysical research communications.

[30]  K. Wang,et al.  Calmodulin-binding proteins as calpain substrates. , 1989, The Biochemical journal.

[31]  A. Himmler Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.

[32]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[33]  K. Jellinger,et al.  Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.

[34]  K. Wang,et al.  Further characterization of calpain-mediated proteolysis of the human erythrocyte plasma membrane Ca2+-ATPase. , 1988, Archives of biochemistry and biophysics.

[35]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[36]  J. Walker,et al.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Robert Siman,et al.  Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo , 1988, Neuron.

[38]  D. Cox,et al.  Human GAP 43: Its deduced amino acid sequence and chromosomal localization in mouse and human , 1988, Neuron.

[39]  G. Lynch,et al.  Ontogeny, compartmentation, and turnover of spectrin isoforms in rat central neurons , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  S. Rogers,et al.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. , 1986, Science.

[41]  H. Wiśniewski,et al.  Are Alzheimer neurofibrillary tangles insoluble polymers? , 1986, Life sciences.

[42]  W. Schlaepfer,et al.  An Immunoblot Study of Neurofilament Degradation In Situ and During Calcium‐Activated Proteolysis , 1985, Journal of neurochemistry.

[43]  H. Kawasaki,et al.  Evolutionary origin of a calcium-dependent protease by fusion of genes for a thiol protease and a calcium-binding protein? , 1984, Nature.

[44]  T. Sasaki,et al.  Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. , 1984, The Journal of biological chemistry.

[45]  J. Wolff,et al.  Calmodulin binds to both microtubule-associated protein 2 and tau proteins. , 1984, The Journal of biological chemistry.

[46]  C. Marotta,et al.  Limited proteolytic modification of a neurofilament protein involves a proteinase activated by endogenous levels of calcium , 1983, Brain Research.

[47]  H. Wiśniewski,et al.  Purification and characterization of two forms of Ca2+-activated neutral protease from calf brain. , 1983, The Journal of biological chemistry.

[48]  D. Selkoe,et al.  Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. , 1982, Science.

[49]  K. Imahori,et al.  Limited autolysis of Ca2+-activated neutral protease (CANP) changes its sensitivity to Ca2+ ions. , 1981, Journal of biochemistry.

[50]  E. Krebs,et al.  Identification of two protease inhibitors from bovine cardiac muscle. , 1978, The Journal of biological chemistry.

[51]  M. Kidd ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY. , 1964, Brain : a journal of neurology.

[52]  D. Hanger,et al.  Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. , 1991, The Biochemical journal.

[53]  Y. Nishizuka,et al.  A calcium‐protease activator associated with brain microsomal‐insoluble elements , 1986, FEBS letters.

[54]  H. Gainer,et al.  Properties of a calcium-activated protease in squid axoplasm which selectively degrades neurofilament proteins. , 1980, Journal of neurobiology.

[55]  R. Mellgren,et al.  Canine cardiac calcium‐dependent proteases: Resolution of two forms with different requirements for calcium , 1980, FEBS letters.